SSPL Securities Private Limited

Friday 27 Jun, 2025 12:10 AM

Harsha Engg rises after subsidiary begins commercial production at new Gujarat plant Infibeam Avenues Ltd leads losers in 'A' group ICRA upgrades LT rating of Updater Services to 'AA-' with 'stable' outlook Fertilizers & Chemicals Travancore Ltd leads losers in 'B' group Aurionpro Solutions edges higher after securing contract for AFC system in Egypt Brahmaputra Infra gains on bagging Rs 17-cr order from NHAI Volumes soar at Brainbees Solutions Ltd counter Cummins India gains on launching Battery Energy Storage Systems Lupin launches Prucalopride tablets in U.S. market Abbott India Ltd soars 3.58%, up for third straight session HDFC Life Insurance Company Ltd gains for third straight session Jio Financial Services Ltd spurts 2.14% ICICI Prudential Life Insurance Company Ltd soars 2.2% Bharat Petroleum Corporation Ltd soars 1.71%, Gains for third straight session Aegis Logistics Ltd up for third straight session

Saravan Stocks

Hot Pursuit

Scrips, which has significant changes during the market hours.

Lupin launches Prucalopride tablets in U.S. market

26-Jun-25 13:12 Hrs IST

Prucalopride Tablets are the bioequivalent of Motegrity' Tablets, developed by Takeda Pharmaceuticals U.S.A., Inc. The medication is indicated for the treatment of chronic idiopathic constipation (CIC) in adult patients.

According to IQVIA MAT data for April 2025, the reference drug Motegrity' recorded annual sales of approximately $184 million in the U.S. market.

Lupin is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. It specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients.

The company's consolidated net profit surged 114.9% to Rs 772.52 crore on a 13.6% jump in net sales to Rs 5,562.20 crore in Q4 FY25 over Q4 FY24.

The scrip declined 1.11% to Rs 1,913.70 on the BSE.

Powered by Capital Market - Live News

Attention Investors :

Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.

Attention Investors :

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.

Attention Investors :

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Attention Investors :

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Email ID: info@ssplwealth.com Customers grievances : grievances@ssplwealth.com Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com, Mobile No: 7305522205

Hit Count : 42233662

Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified)